학술논문
Anti-Herpes zoster vaccination in patients with dermatologic diseases: a position statement from the Italian SIDeMaST group of sexually transmitted, infectious and tropical diseases.
Document Type
Academic Journal
Author
Ciccarese G; Section of Dermatology, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Drago F; Section of Dermatology, Department of Health Sciences (DISSAL), IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.; Herzum A; Unit of Dermatology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.; Atzori L; Unit of Dermatology, Department Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.; Dattola A; Unit of Dermatology, Department of Internal Medicine and Medical Specialties, Sapienza University, Rome, Italy.; Galluzzo M; Department of Systems Medicine, Tor Vergata University, Rome, Italy.; Dermatology Unit, Tor Vergata Polyclinic Foundation, Rome, Italy.; Maronese C; Unit of Dermatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Patrizi A; Unit of Dermatology, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Piraccini BM; Unit of Dermatology, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.; Unit of Dermatology, University Hospital of Bologna, Bologna, Italy.; Recalcati S; Unit of Dermatology, Alessandro Manzoni Hospital, ASST Lecco, Lecco, Italy.; Fargnoli MC; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.; Marzano AV; Unit of Dermatology, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.; Department of Pathophysiology and Transplantation, University of Milan, Milan, Italy.; Papini M; Terni Dermatology Clinic, Terni, Italy - manuelapapini@tiscali.it.; University of Perugia, Perugia, Italy.
Source
Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 101778002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2784-8450 (Electronic) Linking ISSN: 27848671 NLM ISO Abbreviation: Ital J Dermatol Venerol Subsets: MEDLINE
Subject
Language
English
Abstract
Herpes zoster (HZ) is a condition caused by the reactivation of varicella-zoster virus (VZV), the virus responsible for chickepox, which is the clinical manifestation of the primary infection. Congenital or acquired immune system deficiencies, as well as the physiological decline in immune response occurring in the elderly, known as immune senescence, can allow VZV reactivation and, consequently, HZ. One out of 3 people develops HZ during their lifetime. Moreover, thirty percent of the affected subjects develop post-herpetic neuralgia, the most frequent complication after HZ skin rash. Patients with dermatological conditions characterized by alteration of the immune system, such as systemic lupus erythematosus, psoriasis, atopic dermatitis, bullous diseases, and cutaneous lymphomas, are at higher risk of developing HZ and post-herpetic neuralgia, even when their disease is in remission. In the present work, we described the currently available vaccinations against HZ and provided recommendations for the vaccination against HZ in patients with dermatological diseases.